Clinical Trial Detail

NCT ID NCT03384940
Title DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Daiichi Sankyo Co., Ltd.
Indications

colorectal adenocarcinoma

Therapies

DS-8201a

Age Groups: senior adult

Additional content available in CKB BOOST